Octagon Capital Advisors LP Zai Lab LTD Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ZLAB
# of Institutions
124Shares Held
39.9MCall Options Held
41.2KPut Options Held
190K-
Wellington Management Group LLP Boston, MA6.66MShares$115 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA5.68MShares$98.5 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$76.7 Million0.04% of portfolio
-
Woodline Partners LP San Francisco, CA2.6MShares$45 Million0.4% of portfolio
-
Viking Global Investors LP2.05MShares$35.5 Million0.12% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $1.7B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...